NOW L-Carnitine (Tablets) Key Features Purest Form, Clinically Tested Boosts Cellular Energy Transports Fatty Acids NOW L-Carnitine - Tablets - Amino Acids What Is NOW L-Carnitine
Wysocki VH, Resing KA, Zhang Q, Cheng G

The following table shows, as of December 31, 2019, on a pro forma as adjusted basis described above, the differences between the existing stockholders and the purchasers of shares in this offering with respect to the number of shares purchased from us, the total consideration paid, which includes net proceeds received from the issuance of common and convertible preferred stock, cash received from the exercise of stock options, and the value of any stock issued for services and the average price paid per share (in thousands, except per share amounts and percentages): Each $1.00 increase (decrease) in the assumed initial public offering price of $ per share, which is the midpoint of the estimated price range set forth on the cover of this prospectus, would increase (decrease) total consideration paid by new investors and total consideration paid by all stockholders by approximately $ million, assuming that the number of shares offered, as set forth on the cover of this prospectus, remains the same, and after deducting estimated underwriting discounts and commissions

The goal is to create an internal environment that is primed for regeneration on multiple fronts
Expanding cell clusters through recruitment of cell proliferation could help maintain normal blood glucose levels, potentially compensating for cell loss or dysfunction in diabetes (Sjholm, 1996)